NasdaqCM - Delayed Quote USD

AdaptHealth Corp. (AHCO)

9.96 +0.38 (+3.97%)
At close: April 26 at 4:00 PM EDT
9.96 0.00 (0.00%)
After hours: April 26 at 4:20 PM EDT
Key Events
Loading Chart for AHCO
DELL
  • Previous Close 9.58
  • Open 9.69
  • Bid 9.90 x 100
  • Ask 9.96 x 300
  • Day's Range 9.59 - 9.96
  • 52 Week Range 6.37 - 15.37
  • Volume 1,047,955
  • Avg. Volume 1,154,085
  • Market Cap (intraday) 1.324B
  • Beta (5Y Monthly) 1.11
  • PE Ratio (TTM) --
  • EPS (TTM) -5.31
  • Earnings Date May 7, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 11.85

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also offers wheelchairs, hospital beds, oxygen concentrators, CPAP masks and related supplies, wound care supplies, diabetes management supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.

adapthealth.com

10,700

Full Time Employees

December 31

Fiscal Year Ends

Recent News: AHCO

Performance Overview: AHCO

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

AHCO
36.63%
S&P 500
6.92%

1-Year Return

AHCO
13.32%
S&P 500
25.26%

3-Year Return

AHCO
66.13%
S&P 500
22.00%

5-Year Return

AHCO
0.99%
S&P 500
74.29%

Compare To: AHCO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AHCO

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    1.32B

  • Enterprise Value

    3.54B

  • Trailing P/E

    --

  • Forward P/E

    12.15

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.42

  • Price/Book (mrq)

    0.91

  • Enterprise Value/Revenue

    1.11

  • Enterprise Value/EBITDA

    -16.81

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -21.21%

  • Return on Assets (ttm)

    3.34%

  • Return on Equity (ttm)

    -37.24%

  • Revenue (ttm)

    3.2B

  • Net Income Avi to Common (ttm)

    -678.89M

  • Diluted EPS (ttm)

    -5.31

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    81.61M

  • Total Debt/Equity (mrq)

    156.45%

  • Levered Free Cash Flow (ttm)

    176.41M

Research Analysis: AHCO

Analyst Price Targets

7.00 Low
11.85 Average
9.96 Current
16.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: AHCO

Fair Value

9.96 Current
 

Dividend Score

0 Low
AHCO
Sector Avg.
100 High
 

Hiring Score

0 Low
AHCO
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
AHCO
Sector Avg.
100 High
 

Research Reports: AHCO

  • AHCO: What does Argus have to say about AHCO?

    ADAPTHEALTH CORP has an Investment Rating of SELL; a target price of $9.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.

    Rating
    Price Target
     
  • AHCO: What does Argus have to say about AHCO?

    ADAPTHEALTH CORP has an Investment Rating of SELL; a target price of $9.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.

    Rating
    Price Target
     
  • AHCO: What does Argus have to say about AHCO?

    ADAPTHEALTH CORP has an Investment Rating of SELL; a target price of $9.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.

    Rating
    Price Target
     
  • AHCO: What does Argus have to say about AHCO?

    ADAPTHEALTH CORP has an Investment Rating of SELL; a target price of $9.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.

    Rating
    Price Target
     

People Also Watch